![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)
Articles Tagged: CHEK2
October 18, 2023
Breast Cancer Awareness Month: CHEK2 with Petra Kleiblova and Zdenek Kleibl
Petra Kleiblova and Dr. Zdenek Kleib’s commentary on ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast…
BRCA1 & 2
Breast Cancer Awareness
CHEK2
April 14, 2017
Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer
Mayo Clinic and Dr. Fergus Couch collaborate with Ambry Genetics in the largest genetic study to date of women with breast cancer.
ATM
BARD1
BRCA1 & 2
Breast Cancer
CHEK2
HBOC
Mayo Clinic
NCCN
PALB2
RAD51D
December 23, 2016
New Research on Male Breast Cancer: Unexpected Results and Insights
Ambry Genetics, Huntsman Cancer Institute and Mayo Clinic conduct largest reported study of men with breast cancer undergoing multi-gene panel testing.
BRCA1 & 2
CHEK2
Huntsman Cancer Institute
Male Breast Cancer
Mayo Clinic
PALB2
December 14, 2016
Dr. Fergus Couch Talks with Ambry about Recent Study Findings
Mayo Clinic Researcher Dr. Fergus Couch talks with Ambry about recent findings from the largest hereditary breast cancer patient study to date.
ATM
BARD1
BRCA1 & 2
Breast Cancer
CHEK2
Mayo Clinic
RAD51D
